bromopyruvic acid glutathione 3-Bromopyruvic (Bromopyruvic acid) | Hexokinase II Inhibitor 3-Bromopyruvate overcomes cetuximab resistance in
3 Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy dependent ferroptosis Cancer Gene Therapy The promising anticancer drug 3 bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence based view ScienceDirect 3 Bromopyruvate Conjugated Nanoplatform Induced Pro Death Autophagy for Enhanced Photodynamic Therapy against Hypoxic Tumor ACS Nano Induction of Ferroptosis by Dual Targeting pH Responsive Nanomicelles in the Treatment of Tamoxifen Resistant Breast Cancer ACS Applied Nano Materials Anticancer agent 3 bromopyruvic acid forms a conjugate with glutathione Pharmacological Reports Springer Nature Link
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 21 - Sep 26




